Related Tags >> Amgen Anemia drugs pharmaceuticals Cancer

Aranesp News

Most Popular Aranesp Story

Amgen CEO: "I felt real economic pain"

May 8, 2008 — 6:59am ET

What do you do when your biggest therapeutic earners are swooning, your stock price is down and analysts have turned scornful? Look for that silver lining. That was Read more...

Aranesp Press Releases

FDA Receives New Data on Risks of Anemia Drugs
PRESS RELEASE: Amgen Announces Interim Results of Aranesp ''PREPARE'' Study in Breast Cancer Patients
PRESS RELEASE: Phase 2 Study Suggests That Extended Dosing of Aranesp is as Efficacious as Weekly Dosing

Latest Headlines

Amgen CEO: "I felt real economic pain"
May 8, 2008
ALSO NOTED: Dr. Reddy's buys small molecules biz; Labopharm appeals FDA decision; Avant touts typhoid fever data; and much more
April 1, 2008
Amgen forecast darkens as FDA review looms
March 13, 2008
ALSO NOTED: Light Sciences withdraws IPO; Medicare to restrict anemia meds?; and much more...
February 11, 2008
ALSO NOTED: Anemia drugs back in the spotlight; Biodel completes VIAject enrollment; and much more...
January 4, 2008
Amgen platelet therapy hits endpoint in Phase III
December 10, 2007
Aranesp flunks late-stage trial for breast cancer
December 3, 2007
Mircera gets FDA nod, but blocked by patent case
November 15, 2007
Amgen income hammered as anemia drug use drops
October 26, 2007
ALSO NOTED: CHMP issues negative opinion on Zavesca;Wyeth CEO discusses the FDA; and much more...
October 19, 2007
ALSO NOTED: Zingo data lifts Anesiva stock; Two chemo drugs win approvals; BrainStorm plans trials; and much more...
October 17, 2007
SPOTLIGHT: Amgen touts Aranesp data
September 26, 2007

Paid Research Reports